Diabetes

Cancer prevalence higher with long duration of diabetes

(HealthDay)—Patients diagnosed with type 2 diabetes have a greater prevalence of cancer with longer diabetes duration and with insulin use, according to a study published online Jan. 8 in Diabetes Care.

Medications

Added benefit of saxagliptin/metformin combination is not proven

The fixed combination of the drugs saxagliptin and metformin (Komboglyze) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the "Act ...

Diabetes

Which blood sugar monitor is best?

Monitoring the level of glucose (sugar) in your blood is vital if you have diabetes. You get results in real-time, which allows you to adjust your medications, exercise and food accordingly.

Diabetes

Global type 1 diabetes burden remains high despite advances

The past few years have seen numerous advances in the understanding of how type 1 diabetes develops and how to manage it, yet the global disease burden remains high, according to a review article published April 5 in The ...

Diabetes

Glyburide, metformin have similar effect in gestational DM

(HealthDay)—For patients with gestational diabetes mellitus (GDM), glyburide and metformin are comparable in terms of glucose control and safety, according to a study published online Jan. 11 in Diabetes Care.

Diabetes

Number of U.S. kids with diabetes could skyrocket, study finds

(HealthDay)—If the current trends in diabetes for young people stay the same, rates of type 2 diabetes will rise by 49 percent by 2050, and rates of type 1 diabetes will increase by 23 percent, according to new government ...

page 13 from 18